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ABSTRACT 
Intestinal preservation-reperfusion injury may result in various degrees of mucosal injury. Intestinal 
preservation-reperfusion injury may result in various degrees of mucosal injury. Interestingly, the 
preservation injury is similar when using the current preservation solutions, which are given as a 
intravascular flush. An extensive mucosal injury may ultimately preclude the use of organs that 
require longer preservation time.  The intestine lacks a noninvasive rejection marker, as in the case of 
liver or kidney transplantation. Several biomolecules have been suggested as biomarkers, yet their 
specificity is only partial. 
 
Methods: Using a rat intestinal transplant model we studied the pharmacologic donor preconditioning 
and the intraluminal preservation with two different macromolecular solutions as means to decrease 
the intestinal preservation-reperfusion injury. We also investigated the impact of donor 
preconditioning on the ensuing systemic inflammatory response after transplantation.  We analyzed 
resistin levels after clinical intestinal transplantation and seek to establish its significance and potential 
as rejection marker.  
 
Results: Intraluminal introduction of low-sodium macromolecular solutions resulted in improved 
morphology after 8h and 14h of preservation compared with controls receiving only vascular flush 
with UW-solution. Moreover, intraluminal high-sodium solutions appear detrimental. These solutions 
also seem to influence differently the TJ conformation during preservation and delocalization of 
claudin-3 and ZO-1 was more prominent in intraluminal high-sodium solutions.  
Following transplantation, pretreated grafts showed accelerated repair and improved morphology. 
Pretreated grafts revealed reduced NF-kappaB activation after reperfusion and subsequently blunted 
ICAM-1 expression and PMN sequestration.  Pretreated graft recipients had milder liver injury and 
lower levels of the proinflammatory cytokines TNF-alpha, IL-1beta and IL-6 than recipients of 
untreated grafts. 
Resistin levels were studied in seven patients receiving intestinal grafts. Resistin increased in all 
patients compared with controls and remained increased even during uneventful course. Resistin did 
not correlate with CRP, BMI, procalcitonin or WBC and it varied greatly between patients.  
 
Conclusions: Preservation-reperfusion injury may be mitigated by the intraluminal introduction of 
macromolecular solutions or by donor pretreatment with FK506 before graft harvesting. FK506-
pretreated grafts trigger a lower remote organ injury and lower systemic inflammatory response.  
Plasma resistin levels greatly and were  increased in all patients. However, the increase was unspecific 
and varied between individuals. Resistin appears unsuitable as rejection marker after intestinal 
transplantation. 
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